Based on this hypothesis and the results of our study, we propose that there is a “LINC01410-miR532-5p-NCF2-NF-κB” positive feedback loop (Fig. 7g), which plays a vital role in regulating the malignant behavior of GC cells, and might provide a potential therapeutic strategy for treating GC. Here, NFKB1 is linked to gastric cancer.